Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. View full journal description
This journal is a member of the Committee on Publication Ethics (COPE).
Browse by
Articles most recently published online for this journal.
Most read articles in this journal in the last 6 months.
Most cited articles published in this journal in the last 3 years. These statistics are updated weekly using data sourced exclusively from CrossRef.
Articles with the highest Altmetric score from the last 3 months, indicating influence and impact.
You might be interested in
Publish with us
Authors will enjoy:
- Rigorous peer review of your research
- Prompt publishing
- Multidisciplinary audience
- High visibility for global exposure
CBM opens its research
Starting with the first issue of Volume 39, CBM became a Gold Open Access journal. All articles published after January 1, 2024 are permanently openly available online for readers to view, download and share.
Sage discipline hubs
Explore the content from across our disciplines, including the latest journal articles, special issues, and related books and digital library content.
Call for Applications
Cancer Biomarkers is looking for a Deputy Editor to join our team.
Facebook
X
LinkedIn
YouTube
RSS feed
Email alerts